Literature DB >> 30788761

Coexistence of cardiac amyloidosis with coronary artery disease and the challenges in medical management.

Vasvi Singh1, Alexander Tiemeier1, Saurabh Malhotra2,3.   

Abstract

Entities:  

Year:  2019        PMID: 30788761     DOI: 10.1007/s12350-019-01644-9

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  23 in total

1.  Troponin levels in patients with amyloid cardiomyopathy undergoing cardiac transplantation.

Authors:  W L Miller; R S Wright; C G McGregor; A Dispenzieri; J P McConnell; M F Burritt; A S Jaffe
Journal:  Am J Cardiol       Date:  2001-10-01       Impact factor: 2.778

Review 2.  Diagnosis and management of the cardiac amyloidoses.

Authors:  Rodney H Falk
Journal:  Circulation       Date:  2005-09-27       Impact factor: 29.690

3.  Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis.

Authors:  Dermot Phelan; Patrick Collier; Paaladinesh Thavendiranathan; Zoran B Popović; Mazen Hanna; Juan Carlos Plana; Thomas H Marwick; James D Thomas
Journal:  Heart       Date:  2012-08-03       Impact factor: 5.994

4.  Syncope in cardiac amyloidosis and chronic ischemic heart disease: A case report.

Authors:  Giacomo Mugnai; Mariantonietta Cicoira; Andrea Rossi; Corrado Vassanelli
Journal:  Exp Clin Cardiol       Date:  2011

5.  Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial.

Authors:  John L Berk; Ole B Suhr; Laura Obici; Yoshiki Sekijima; Steven R Zeldenrust; Taro Yamashita; Michael A Heneghan; Peter D Gorevic; William J Litchy; Janice F Wiesman; Erik Nordh; Manuel Corato; Alessandro Lozza; Andrea Cortese; Jessica Robinson-Papp; Theodore Colton; Denis V Rybin; Alice B Bisbee; Yukio Ando; Shu-ichi Ikeda; David C Seldin; Giampaolo Merlini; Martha Skinner; Jeffery W Kelly; Peter J Dyck
Journal:  JAMA       Date:  2013-12-25       Impact factor: 56.272

6.  (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.

Authors:  Sabahat Bokhari; Adam Castaño; Ted Pozniakoff; Susan Deslisle; Farhana Latif; Mathew S Maurer
Journal:  Circ Cardiovasc Imaging       Date:  2013-02-11       Impact factor: 7.792

7.  Syncope from dynamic left ventricular outflow tract obstruction simulating hypertrophic cardiomyopathy in a patient with primary AL-type amyloid heart disease.

Authors:  José-Luis E Velazquez-Ceceña; David L Lubell; Nagapradeep Nagajothi; Hytham Al-Masri; Mumtaz Siddiqui; Sandeep Khosla
Journal:  Tex Heart Inst J       Date:  2009

8.  Pathophysiology of technetium-99m stannous pyrophosphate and thallium-201 scintigraphy of acute anterior myocardial infarcts in dogs.

Authors:  L M Buja; R W Parkey; E M Stokely; F J Bonte; J T Willerson
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

9.  Digoxin sensitivity in amyloid cardiomyopathy.

Authors:  A Rubinow; M Skinner; A S Cohen
Journal:  Circulation       Date:  1981-06       Impact factor: 29.690

10.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Authors:  Julian D Gillmore; Mathew S Maurer; Rodney H Falk; Giampaolo Merlini; Thibaud Damy; Angela Dispenzieri; Ashutosh D Wechalekar; John L Berk; Candida C Quarta; Martha Grogan; Helen J Lachmann; Sabahat Bokhari; Adam Castano; Sharmila Dorbala; Geoff B Johnson; Andor W J M Glaudemans; Tamer Rezk; Marianna Fontana; Giovanni Palladini; Paolo Milani; Pierluigi L Guidalotti; Katarina Flatman; Thirusha Lane; Frederick W Vonberg; Carol J Whelan; James C Moon; Frederick L Ruberg; Edward J Miller; David F Hutt; Bouke P Hazenberg; Claudio Rapezzi; Philip N Hawkins
Journal:  Circulation       Date:  2016-04-22       Impact factor: 29.690

View more
  1 in total

1.  Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.

Authors:  Nicolò Martini; Stefania Rizzo; Cristiano Sarais; Alberto Cipriani
Journal:  BMC Cardiovasc Disord       Date:  2020-10-29       Impact factor: 2.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.